Cormorant Asset Management

Cormorant Asset Management as of June 30, 2016

Portfolio Holdings for Cormorant Asset Management

Cormorant Asset Management holds 84 positions in its portfolio as reported in the June 2016 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Alder Biopharmaceuticals 6.0 $42M 1.7M 24.97
Nevro (NVRO) 5.1 $36M 491k 73.76
Heron Therapeutics (HRTX) 4.5 $32M 1.8M 18.05
Tesaro 4.3 $31M 363k 84.05
Nektar Therapeutics (NKTR) 4.1 $29M 2.0M 14.23
Minerva Neurosciences 4.0 $29M 2.8M 10.21
Theravance Biopharma (TBPH) 3.6 $25M 1.1M 22.69
Sage Therapeutics (SAGE) 3.1 $22M 730k 30.13
Eagle Pharmaceuticals (EGRX) 2.8 $20M 506k 38.79
Macrogenics (MGNX) 2.7 $19M 708k 26.99
Vitae Pharmaceuticals 2.7 $19M 1.8M 10.79
Galapagos Nv- (GLPG) 2.6 $18M 334k 54.92
Neurocrine Biosciences (NBIX) 2.6 $18M 398k 45.45
Omeros Corporation (OMER) 2.5 $18M 1.7M 10.52
Aclaris Therapeutics (ACRS) 2.4 $17M 901k 18.47
Proteostasis Therapeutics In 2.3 $16M 1.4M 12.13
Clearside Biomedical (CLSD) 2.0 $14M 2.0M 7.01
Cellectis S A (CLLS) 1.9 $13M 498k 26.59
Ardelyx (ARDX) 1.9 $13M 1.5M 8.73
China Biologic Products 1.7 $12M 113k 106.32
Quotient 1.7 $12M 1.5M 7.75
Sorrento Therapeutics (SRNE) 1.7 $12M 2.1M 5.60
Novavax 1.7 $12M 1.6M 7.27
Alnylam Pharmaceuticals (ALNY) 1.6 $11M 200k 55.49
Coherus Biosciences (CHRS) 1.4 $9.7M 576k 16.89
Portola Pharmaceuticals 1.3 $9.3M 396k 23.60
Myokardia 1.3 $9.4M 758k 12.40
Dynavax Technologies (DVAX) 1.3 $9.3M 635k 14.58
Relypsa 1.2 $8.3M 450k 18.50
Wave Life Sciences (WVE) 1.2 $8.2M 394k 20.69
Sangamo Biosciences (SGMO) 1.1 $8.1M 1.4M 5.79
Dex (DXCM) 1.1 $7.9M 100k 79.33
Achillion Pharmaceuticals 1.1 $7.8M 1.0M 7.80
Inc Resh Hldgs Inc cl a 1.1 $7.6M 200k 38.13
Seres Therapeutics (MCRB) 1.0 $7.4M 253k 29.05
Advaxis 0.9 $6.6M 810k 8.09
Agenus 0.9 $6.4M 1.6M 4.05
Recro Pharma 0.9 $6.2M 778k 7.95
Forward Pharma A/s 0.9 $6.2M 339k 18.17
Corbus Pharmaceuticals Hldgs 0.8 $6.0M 2.0M 2.99
Ultragenyx Pharmaceutical (RARE) 0.8 $5.4M 111k 48.91
Collegium Pharmaceutical Inc Common Stock Usd (COLL) 0.8 $5.4M 456k 11.85
Pfenex 0.8 $5.3M 633k 8.37
Dermira 0.7 $5.0M 172k 29.25
Acceleron Pharma 0.6 $4.3M 128k 33.98
Agile Therapeutics 0.6 $4.3M 564k 7.61
Atara Biotherapeutics 0.6 $4.2M 187k 22.51
Lion Biotechnologies 0.6 $4.1M 506k 8.10
Cytomx Therapeutics (CTMX) 0.5 $3.8M 372k 10.21
Intec Pharma 0.5 $3.7M 810k 4.60
Immune Design 0.5 $3.5M 433k 8.16
Oncobiologics 0.5 $3.5M 1.0M 3.40
Zynerba Pharmaceuticals 0.5 $3.3M 481k 6.85
Corvus Pharmaceuticals (CRVS) 0.4 $3.1M 214k 14.26
Contrafect 0.3 $2.4M 841k 2.89
Aptose Biosciences 0.3 $2.4M 991k 2.44
Lipocine 0.3 $2.3M 751k 3.04
Agios Pharmaceuticals (AGIO) 0.3 $2.1M 50k 41.90
Glycomimetics (GLYC) 0.3 $2.1M 287k 7.27
Syndax Pharmaceuticals (SNDX) 0.3 $2.1M 214k 9.85
Blueprint Medicines (BPMC) 0.3 $2.0M 101k 20.25
Celyad Sa 0.3 $1.9M 76k 24.97
Curis 0.3 $1.8M 1.2M 1.56
Epizyme 0.2 $1.6M 160k 10.24
Regenxbio Inc equity us cm (RGNX) 0.2 $1.3M 157k 8.00
AVEO Pharmaceuticals 0.1 $1.0M 1.1M 0.96
Aquinox Pharmaceuticals 0.1 $1.0M 152k 6.62
Amicus Therapeutics (FOLD) 0.1 $829k 152k 5.46
Provectus Biopharmaceuticals I (PVCT) 0.1 $824k 2.2M 0.37
Ascendis Pharma A S (ASND) 0.1 $826k 62k 13.27
Tetralogic Pharmaceuticals c note 8.000% 6/1 0.1 $850k 5.0M 0.17
Genvec 0.1 $679k 1.2M 0.57
Threshold Pharmaceuticals 0.1 $648k 1.0M 0.64
Htg Molecular Diagnostics 0.1 $529k 204k 2.60
Nanostring Technologies (NSTGQ) 0.1 $510k 41k 12.60
Neos Therapeutics 0.1 $470k 51k 9.29
Provectus Biopharmaceuticals *w exp 06/24/202 0.1 $418k 2.2M 0.19
Invuity 0.1 $326k 34k 9.53
Applied Genetic Technol Corp C 0.0 $245k 17k 14.14
Adaptimmune Therapeutics (ADAP) 0.0 $206k 25k 8.14
Cellectar Biosciences 0.0 $185k 54k 3.45
Oncobiologics Inc *w exp 02/18/201 0.0 $192k 417k 0.46
Oncobiologics Inc *w exp 05/18/201 0.0 $188k 417k 0.45
Cellectar Biosciences Equity Warrants *w 0.0 $29k 53k 0.55